Eight Percent of U.S. Kids Have ADHD, Survey Finds
Posted on: Thursday, 1 September 2005, 19:30 CDT
WASHINGTON -- Just under 8 percent of U.S. children aged 4 to 17 had ever been diagnosed with attention-deficit hyperactivity disorder in 2003, and more than half of them are being treated with drugs, the U.S. Centers for Disease Control and Prevention reported on Thursday.
Boys are more than twice as likely to be diagnosed with ADHD than girls, especially boys from poorer families, the CDC said.
The 2003 survey is the first comprehensive analysis of precisely how many U.S. children have the disorder and how many are on medication for it, the CDC said in its weekly report in death and disease.
"In 2003, approximately 7.8 percent (4.4 million) of U.S. children aged 4 to 17 years had ever had ADHD diagnosed," the report reads.
Estimates had ranged from anywhere between 2 percent and 18 percent, the CDC said.
It said 2.5 million, or 56 percent, had ever taken medication for the disorder.
"ADHD diagnosis was reported approximately 2.5 times more frequently among males than females. Prevalence of reported ADHD increased with age and was significantly lower among children aged 4 to 8 years compared with children aged more than 9 years."
For the report, the CDC experts analyzed data from the 2003 National Survey of Children's Health.
It said more 6-year-old boys were on medication for ADHD -- 4.3 percent -- than any girl of any age.
"The highest rates of medication treatment for ADHD by sex and age were reported among males aged 12 years (9.3 percent) and among females aged 11 years (3.7 percent)," the CDC said.
To be diagnosed with ADHD a child must have six or more symptoms for six months including frequent failure to pay attention in schoolwork or play, frequent mistakes due to inattention to schoolwork, frequent failure to listen when spoken to directly, failure to follow up on chores and forgetfulness.
"ADHD poses substantial costs both to families and society," the CDC said.
"Health care costs associated with ADHD are conservatively estimated at $3.3 billion annually," it added.
"Moreover, persistent and negative side effects of stimulants have been documented, including sleep disturbances, reduced appetite, and suppressed growth, which might have important health implications for the millions of children who are currently taking medication for ADHD."
Therefore, it said, experts should keep an eye on how many children have ADHD and are being medicated for it.
Source: REUTERS
Related Articles
- Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
- FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD
- DMC Children's Hospital of Michigan Ranked Among America's Best
- FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
- FDA Approves AstraZeneca's Nexium for Children Aged One to 11
- Research and Markets: Fresenius Medical Care Company Intelligence Report Reveals Products, International Activities and R&D, As Well As a Full, In-Depth Five Year Financial Analysis
- Advanced Fertility Center of Chicago's IVF Success Rates Highlighted in CDC National Assisted Reproductive Technology Report
- 8,500 Children Living With HIV/AIDS in Vietnam: Report
- GlaxoSmithKline's Havrix(R) (Hepatitis A Vaccine, Inactivated) Now Approved For Use in Children Aged 12 Months and Older
- National, State, and Urban Area Vaccination Coverage Among Children Aged 19-35 Months - United States, 2004
User Comments (0)


RSS Feeds